The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Lapainol 10 mg/ml solution for injection



Orpha-Devel Handels und Vertriebs GmbHPA1353/002/001

Main Information

Trade NameLapainol 10 mg/ml solution for injection
Active SubstancesNalbuphine hydrochloride
Dosage FormSolution for injection
Licence HolderOrpha-Devel Handels und Vertriebs GmbH
Licence NumberPA1353/002/001

Group Information

ATC CodeN02AF Morphinan derivatives
N02AF02 nalbuphine

Status

License statusAuthorised
Licence Issued03/08/2007
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis product contains a substance listed in Schedule 2 to the Misuse of Drugs Regulations 2017.
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back